Agis Leontakianakos

Capital Genomix, Inc. develops and markets novel antibody based therapeutics. The firm possesses two genomic and proteomic drug development technology platforms, GeneSystem320 and ImmunoMouse. The company was founded in August 2000 and is headquartered in Gaithersburg, MD.

Biotherapeutics, Inc. operates as a pre-clinical stage company which develops small-molecule drugs to treat inflammation and type 2 diabetes. Its scientific foundation is anchored on informatics and computer modeling-enabled drug development with significant animal pharmacology validation. The company was founded by Josep Bassaganya-Riera in 2008 and is headquartered in Blacksburg, VA.

Odyssey offers financial advisory and management consulting services. It services include pre-emptive recapitalizations, acquisitions and sales of distressed companies and assets, and debt and equity restructuring. The firm was founded in 1998 and is headquartered in Phoenix, AZ.

International Equity Development GmbH & Co. KG (IED) is the corporate investment arm of Sterling Investment Group, an investment group based in the British Virgin Islands and controlled by the Swiss businessman Tito Tettamanti. IED is based in Frankfurt with an office in Spain.

Ares Venture Partners, Inc. provides investment services. The private company is based in New York.

Global International Equity Corp. provides investment services. The private company is based in Boca Raton.

Odyssey Capital & Research Group, Inc. provides investment advisory services. The private company is based in Boca Raton.